Redmile Group, LLC

Holdings History for RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT)

Symbol: RAPT on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value
Latest Disclosed Shares Owned: 1,765,303 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Redmile Group, LLC ownership in RAPT Therapeutics, Inc. Common Stock, $0.0001 par value (RAPT)

14 Aug 2025 - Redmile Group, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,765,303 shares of RAPT Therapeutics, Inc. Common Stock, $0.0001 par value (RAPT). This represents 9.9% ownership of the company. This is the first filing by Redmile Group, LLC disclosing ownership of RAPT Therapeutics, Inc. Common Stock, $0.0001 par value (RAPT).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Redmile Group, LLC	9.9%		$14,934,463	1,765,303			$8.46	13G/A	30 Jun 2025	14 Aug 2025, 16:18

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.2%	+0.83%	$30,006,347	885,927	+333,333	+60%	$33.87	Q4 2025
30 Sep 2025	1.4%	-0.2%	$14,251,399	552,594	-78,092	-12%	$25.79	Q3 2025
30 Jun 2025	0.54%	+0.54%	$5,045,488	630,686	+630,686	NEW	$8.00	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.